Recursion Deepens Citeline Partnership to Supercharge AI Drug Discovery Platform
Recursion expands Citeline partnership to integrate real-world data into its AI drug discovery platform, achieving 30-60% trial enrollment improvements.
RXRXstrategic partnershipclinical development